Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Research » Defining NETs – Research project now recruiting

Defining NETs – Research project now recruiting

  • May 2, 2016
 
Defining NETs, funded by the Victorian Cancer Agency, aims to define the differences in patient experience, supportive care needs, psychological well-being and quality of life between those with functioning and non-functioning NETs.

Phase one of this study will be collecting questionnaire and clinical data from patients, newly diagnosed with a NET, over a 6-month period. In phase two of this study, this information will be then used to design, develop, and pilot test, a targeted supportive care intervention tailored to meet the specific needs of each subgroup which will be delivered through the Unicorn Foundation NET-Nurse Hotline. This study is being led by PI: Dr Lisa Guccione and chief investigators Prof Penelope Schofield, A/Prof Michael Michael, A/Prof Nick Pavlakis, Dr Mustafa Khasraw and Dr Tim Price. The study is currently recruiting at the Peter MacCallum Cancer Centre in VIC, Royal North Shore Hospital and Northern Cancer Institute in NSW, Lyell McEwin Hospital in SA, Royal Brisbane Hospital in QLD and Fiona Stanley Hospital in WA opening soon.

PARTICIPANT INCLUSION/EXCLUSION CRITERIA:
Inclusion Criteria:
• Newly diagnosed with a NET (within 6 months), classified as either functioning or non-functioning by the treating oncologist.
• Over 18 years of age
• Proficiency in English

Exclusion criteria
• Too unwell to participate  in the study as determined by the study team
• Severe psychiatric or cognitive disorder

WHAT THE STUDY REQUIRES:
 Consent to access medical records
 Collection of clinical information
 Patients to complete questionnaires at baseline and 6 months follow-up

For any further questions please contact:
Dr Lisa Guccione, PhD
Post-doctoral Research Fellow, Cancer Experiences Research
 
Phone  +61 3 9656 5246

Email lisa.guccione@petermac.org or alexandra.murray@petermc.org

Share this post

Recent posts

Sharon Rickard Completes Run Larapinta 2025!

August 18, 2025

Shane Kent Conquers the World’s Toughest Triathlon for Neuroendocrine Cancer Awareness

August 18, 2025

Turn Your Cans & Bottles into Support for NET Patients

August 12, 2025

National Patient Organisation Network (NPON)

July 24, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousUpdate on NABNEC Study
NextCNSA 2016 Wrap Up By NET Nurse Kate WakelinNext

Related Posts

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NeuroEndocrine Cancer Australia (NECA) was proud to attend the 5th Neuroendocrine Tumour (NET) Preceptorship held 13 & 14th June at Peter MacCallum Cancer Centre in

NECA at ENETS 2025: Advancing NET Care on the Global Stage

NeuroEndocrine Cancer Australia at ENETS 2025: Advancing NET Care on the Global Stage NeuroEndocrine Cancer Australia (NECA) proudly represented Australia at the 22nd Annual European

The Australian Cancer Plan

Shaping the future of cancer control together   We are pleased to send you this update on the Australian Cancer Plan, the first national 10-year

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Read full report

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin